PRICE T ROWE ASSOCIATES INC /MD/ - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$51
-5.6%
36,5000.0%0.00%
Q2 2023$54
-11.5%
36,5000.0%0.00%
Q1 2023$61
+19.6%
36,5000.0%0.00%
Q4 2022$51
-99.9%
36,5000.0%0.00%
Q3 2022$57,000
-28.8%
36,5000.0%0.00%
Q2 2022$80,000
+50.9%
36,500
+69.9%
0.00%
Q1 2022$53,000
-57.3%
21,480
+3.9%
0.00%
Q4 2021$124,000
-98.7%
20,680
-96.1%
0.00%
-100.0%
Q4 2020$9,528,000
+21.3%
529,627
-4.3%
0.00%0.0%
Q3 2020$7,852,000553,3590.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders